Principal Financial Group Inc. lifted its position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 2.7% in the first quarter, Holdings Channel.com reports. The institutional investor owned 347,095 shares of the company’s stock after purchasin…